FAP and fibrosis: Another study reported on the antifibrotic CAR T cells designed against fibroblast activation protein (FAP, a marker of activated fibroblasts): Injections of FAP-CAR-mRNA in CD5-targeted LNPs decreased the burden of fibrotic tissue and improved cardiac function in a mouse model of fibrosis (23).